Intellia Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress
Go back to Intellia Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress| (NASDAQ: NTLA) | Delayed: 16.98 -0.86 (4.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.84 | 52 Week High | $30.40 | |||
| Open | $17.85 | 52 Week Low | $11.86 | |||
| Day High | $18.11 | P/E | N/A | |||
| Day Low | $16.93 | EPS | $0.00 | |||
| Volume | 392,671 | |||||

